Pan MR - Search Results

1

Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.

Hung YH, Wang HC, Pan MR, Chen LT. Hung YH, et al. Among authors: pan mr. J Pers Med. 2024 Feb 20;14(3):224. doi: 10.3390/jpm14030224. J Pers Med. 2024. PMID: 38540967 Free PMC article.

2

G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.

Pan MR, Hsu MC, Chen LT, Hung WC. Pan MR, et al. Sci Rep. 2015 Dec 21;5:18709. doi: 10.1038/srep18709. Sci Rep. 2015. PMID: 26688070 Free PMC article.

3

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

Pan MR, Hsu MC, Luo CW, Chen LT, Shan YS, Hung WC. Pan MR, et al. Oncotarget. 2016 Sep 20;7(38):61136-61151. doi: 10.18632/oncotarget.11256. Oncotarget. 2016. PMID: 27531902 Free PMC article.

4

Orchestration of H3K27 methylation: mechanisms and therapeutic implication.

Pan MR, Hsu MC, Chen LT, Hung WC. Pan MR, et al. Cell Mol Life Sci. 2018 Jan;75(2):209-223. doi: 10.1007/s00018-017-2596-8. Epub 2017 Jul 17. Cell Mol Life Sci. 2018. PMID: 28717873 Free PMC article. Review.

5

Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer.

Tian YF, Wang HC, Luo CW, Hung WC, Lin YH, Chen TY, Li CF, Lin CY, Pan MR. Tian YF, et al. Among authors: pan mr. Am J Cancer Res. 2018 Sep 1;8(9):1812-1822. eCollection 2018. Am J Cancer Res. 2018. PMID: 30323973 Free PMC article.

6

From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis.

Wang HC, Hung WC, Chen LT, Pan MR. Wang HC, et al. Among authors: pan mr. Int J Mol Sci. 2018 Nov 13;19(11):3584. doi: 10.3390/ijms19113584. Int J Mol Sci. 2018. PMID: 30428588 Free PMC article. Review.

7

Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression.

Hsu MC, Pan MR, Chu PY, Tsai YL, Tsai CH, Shan YS, Chen LT, Hung WC. Hsu MC, et al. Among authors: pan mr. Cancers (Basel). 2018 Dec 20;11(1):8. doi: 10.3390/cancers11010008. Cancers (Basel). 2018. PMID: 30577570 Free PMC article.

8

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication.

Hung YH, Hsu MC, Chen LT, Hung WC, Pan MR. Hung YH, et al. Among authors: pan mr. J Clin Med. 2019 Jun 24;8(6):903. doi: 10.3390/jcm8060903. J Clin Med. 2019. PMID: 31238554 Free PMC article. Review.

9

Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.

Hsu MC, Tsai YL, Lin CH, Pan MR, Shan YS, Cheng TY, Cheng SH, Chen LT, Hung WC. Hsu MC, et al. Among authors: pan mr. J Hematol Oncol. 2019 Jul 19;12(1):79. doi: 10.1186/s13045-019-0769-7. J Hematol Oncol. 2019. PMID: 31324208 Free PMC article.

10

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Wang HC, Chou CL, Yang CC, Huang WL, Hsu YC, Luo CW, Chen TJ, Li CF, Pan MR. Wang HC, et al. Among authors: pan mr. Int J Mol Sci. 2019 Aug 21;20(17):4087. doi: 10.3390/ijms20174087. Int J Mol Sci. 2019. PMID: 31438571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters